Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy-Reference-Cited by-同舟云学术

Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy

Published:2010-09-14 Issue:4 Volume:13 Page:307-310
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Manoharan M,Eldefrawy A,Katkoori D,Antebi E,Soloway M S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/pcan201034.pdf

Reference17 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ . Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225–249.

2. Cooperberg MR, Moul JW, Carroll PR . The changing face of prostate cancer. J Clin Oncol 2005; 23: 8146–8151.

3. Klotz L . Active surveillance for prostate cancer: trials and tribulations. World J Urol 2008; 26: 437–442.

4. Zietman A . Active surveillance: a safe, low-cost prognostic test for prostate cancer. BJU Int 2008; 101: 1059–1060.

5. Soloway MS, Soloway CT, Williams S, Ayyathurai R, Kava B, Manoharan M . Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int 2008; 101: 165–169.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active Surveillance vs Immediate Treatment—Which Has a Greater Financial Incentive for Urologists?;Urology Practice;2020-05

2. Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy–a claims data analysis;BMC Health Services Research;2016-11-18

3. The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer: Consensus Statement With Recommendations Supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation;Archives of Pathology & Laboratory Medicine;2014-10

4. The economics of active surveillance for prostate cancer;Current Opinion in Urology;2013-05

5. Beyond Prostate-specific Antigen — Future Biomarkers for the Early Detection and Management of Prostate Cancer;Clinical Oncology;2012-10